O Paulo, Brazil. Patients on treatment for at least 3 months were approached to participate in the study. Exclusion criteria included age less than 18 years, presence of chronic inflammatory disease, active malignancy, human immunodeficiency virus, viral hepatitis, and chronic use of steroids. The majority of the patients were on regular use of angiotensinconverting enzyme inhibitors (81 ) and diuretics (76 ). Patients were also under use of b-blockers (44 ), calcium Disease [20,21]. Many studies have shown that not only metabolic regulation but channel blockers (40 ), statins (32 ) and angiotensin receptor blockers (22 ). Thirty five patients (33 ) were using sevelamer, six patients (5 ) were taking calcium-based phosphate binders, and six patients (5 ) were taking calcitriol. Five patients were using erythropoiesisstimulating agents. Written informed consent was obtained from all participants. This study was reviewed and approved by the Ethics Advisory Committee of the Federal University of Sao Paulo (approval number 60806).24-hour ambulatory blood pressure monitoringThe 24-hour blood pressure monitoring was performed using Dyna equipment (Cardios, Sao Paulo, Brazil). Oscillometer was adjusted to systolic blood pressure varying between 290 and 70, and diastolic blood pressure varying between 180 and 45 mmHg, and memory of up to 300 measurements/events. Blood pressure (BP) measurements were obtained at intervals of 20 minutes Catabolic enzyme spermidine/spermine N1-acetyl transferase 1 (Sat1) were increased in during the day and 30 minutes during sleep. Participants were instructed to keep their habitual routine during the 24-h period and to pause momentarily during each BP measurement. Dipping ( ) is defined by percent decrease in nighttime systolic-diastolic BP blood pressure compared to daytime systolic-diastolic BP. When patients exhibited dipping of less than 10 , they were defined as non-dippers [14]. Hypertension was defined as blood pressure greater than 140/90 mmHg or use of antihypertensive medication.Coronary computed tomographyPatients underwent coronary artery calcification (CAC) quantification by a multi-slice computed tomography scanner (LightSpeedH Pro 16; GE Healthcare, Milwaukee, WI, USA), using a gantry rotation of 0.4 seconds, collimation of 2.5 mm (slice thickness), and reconstruction time of six frames per second. A calcium threshold of 130 or more Hounsfield Units was used. The images were scored by a single 23148522 radiologist blinded to the clinical and biochemical aspects of the patient. As described by Agatston et al. [15], the calcium score was determined by multiplying the area of each calcified lesion by a weighting factor corresponding to the peak pixel intensity for each lesion. The sum of each lesion of all coronary arteries was used for analysis. Presence of calcification was defined as CAC score .10 Agatston units (AU) and severe calcification as CAC score 400 AU.Study design and protocolIn this cross-sectional study all patients underwent clinical history assessment, laboratory tests and cardiac evaluation within a month. Demographic data, cardiovascular risk factors, comorbidities and family history were also evaluated. Nutritional status was evaluated by the subjective global assessment [10].Laboratory testsBlood samples were drawn in a 12-hour fasting state. Biochemical and hematological parameters included serum creatinine, hemoglobin, potassium, magnesium, lipid profile, ionized calcium, phosphate, alkaline phosphatase, intact parathyroid hormone (iPTH – chemiluminescence imunoassay; Immulite; DPC-Biermann, Bad Nauheim, Germany ; reference values 10 to 65 pg/.O Paulo, Brazil. Patients on treatment for at least 3 months were approached to participate in the study. Exclusion criteria included age less than 18 years, presence of chronic inflammatory disease, active malignancy, human immunodeficiency virus, viral hepatitis, and chronic use of steroids. The majority of the patients were on regular use of angiotensinconverting enzyme inhibitors (81 ) and diuretics (76 ). Patients were also under use of b-blockers (44 ), calcium channel blockers (40 ), statins (32 ) and angiotensin receptor blockers (22 ). Thirty five patients (33 ) were using sevelamer, six patients (5 ) were taking calcium-based phosphate binders, and six patients (5 ) were taking calcitriol. Five patients were using erythropoiesisstimulating agents. Written informed consent was obtained from all participants. This study was reviewed and approved by the Ethics Advisory Committee of the Federal University of Sao Paulo (approval number 60806).24-hour ambulatory blood pressure monitoringThe 24-hour blood pressure monitoring was performed using Dyna equipment (Cardios, Sao Paulo, Brazil). Oscillometer was adjusted to systolic blood pressure varying between 290 and 70, and diastolic blood pressure varying between 180 and 45 mmHg, and memory of up to 300 measurements/events. Blood pressure (BP) measurements were obtained at intervals of 20 minutes during the day and 30 minutes during sleep. Participants were instructed to keep their habitual routine during the 24-h period and to pause momentarily during each BP measurement. Dipping ( ) is defined by percent decrease in nighttime systolic-diastolic BP blood pressure compared to daytime systolic-diastolic BP. When patients exhibited dipping of less than 10 , they were defined as non-dippers [14]. Hypertension was defined as blood pressure greater than 140/90 mmHg or use of antihypertensive medication.Coronary computed tomographyPatients underwent coronary artery calcification (CAC) quantification by a multi-slice computed tomography scanner (LightSpeedH Pro 16; GE Healthcare, Milwaukee, WI, USA), using a gantry rotation of 0.4 seconds, collimation of 2.5 mm (slice thickness), and reconstruction time of six frames per second. A calcium threshold of 130 or more Hounsfield Units was used. The images were scored by a single 23148522 radiologist blinded to the clinical and biochemical aspects of the patient. As described by Agatston et al. [15], the calcium score was determined by multiplying the area of each calcified lesion by a weighting factor corresponding to the peak pixel intensity for each lesion. The sum of each lesion of all coronary arteries was used for analysis. Presence of calcification was defined as CAC score .10 Agatston units (AU) and severe calcification as CAC score 400 AU.Study design and protocolIn this cross-sectional study all patients underwent clinical history assessment, laboratory tests and cardiac evaluation within a month. Demographic data, cardiovascular risk factors, comorbidities and family history were also evaluated. Nutritional status was evaluated by the subjective global assessment [10].Laboratory testsBlood samples were drawn in a 12-hour fasting state. Biochemical and hematological parameters included serum creatinine, hemoglobin, potassium, magnesium, lipid profile, ionized calcium, phosphate, alkaline phosphatase, intact parathyroid hormone (iPTH – chemiluminescence imunoassay; Immulite; DPC-Biermann, Bad Nauheim, Germany ; reference values 10 to 65 pg/.
